Skip to content
MMetabolicMomsTHE MAGAZINE FOR MOTHERS ON GLP-1
Menu

Guide · Cost & Coverage

How to Get a GLP-1 Without Insurance

The real routes to a GLP-1 when your plan won't cover it — telehealth, compounding pharmacies, manufacturer cash programs — and how to choose between them.

By Tessa Bloom, Contributing Editor, Cost & Coveragea disclosed pen name for the MetabolicMoms desk

Fact-checked against the record by Reed Ellsworth, who reviews the evidence as a former pharma-industry analyst — never as your clinician.

The short answer

You do not need insurance to start a GLP-1. There are three working routes for a cash-paying mother: a telehealth clinic that prescribes and ships a compounded semaglutide or tirzepatide, a manufacturer's direct cash program for a brand-name drug, or a local prescriber plus a cash pharmacy price. The fastest and usually cheapest is telehealth compounded care; the most FDA-solid is a brand drug through a maker's cash program. Which is right depends on your budget and your comfort with a non-FDA-approved product. Here is how each route actually works.

First, know what you're eligible for

GLP-1 weight-management medicines are prescribed against clinical criteria, not insurance status — generally a body-mass index in the obesity range, or the overweight range with a weight-related condition. A prescriber makes that call, and a legitimate route always involves one. That is true whether you go through a telehealth intake form or sit in an office. The evidence base behind the prescription is real: semaglutide produced about 15% mean weight loss in the STEP 1 trial1 and tirzepatide near 20% in SURMOUNT-12, which is why clinicians treat these as long-term metabolic medicines rather than a quick fix. If you are brand new to all of this, read starting a GLP-1 as a first-timer alongside this piece.

Route 1 — Telehealth with compounded medication (usually cheapest)

This is the path most cash-paying mothers actually take. You complete a medical intake online, a licensed clinician reviews it, and if appropriate a compounding pharmacy ships a compounded semaglutide or tirzepatide. It is typically the lowest monthly cost and the least friction. The trade-off is real and worth stating plainly: compounded drugs are not FDA-approved and were not the exact products in the trials, and the FDA has publicly raised concerns about unapproved GLP-1 products sold for weight loss3. Choose a provider that is transparent about which drug, which dose, and which pharmacy — and that states one all-in price.

A legitimate route always runs through a real prescriber. If a site skips the clinician entirely, that is a red flag, not a shortcut.

Route 2 — A manufacturer's direct cash program (most FDA-solid)

Brand-name makers now sell some GLP-1 vials directly to cash patients at prices below the old list figure. You still need a prescription, and the monthly cost is generally higher than compounded — but you are getting the exact FDA-approved product that was studied, which matters to some families more than the savings. There is also an oral option: an oral semaglutide pill has been studied at higher doses for weight loss4, which can appeal if needles are the barrier. Compare the all-in monthly number, not the format.

Route 3 — Local prescriber plus a cash pharmacy price

The traditional path still works: see a primary-care doctor or an obesity-medicine clinician, get a prescription, and pay a cash or discount-card price at a pharmacy. It is often the most expensive route for a brand drug, but it gives you an in-person relationship and someone local monitoring you — worth a lot if you have other health conditions or are navigating what to tell your OB before starting.

How to choose without getting burned

Price the *maintenance* dose, not the intro dose, because the dose climbs as the drug starts working — and this is a standing cost, not a one-month buy. When semaglutide was stopped in the STEP 4 trial, participants regained much of the weight5, so plan for a recurring bill. Favor one flat, all-in monthly price with the clinician included and no step-up as you titrate. That standard is why our editors rank CoreAge Rx first for cash-pay families. To compare the field, see the cheapest GLP-1 without insurance and how much a GLP-1 actually costs out of pocket; if there is any chance of coverage, check the best providers for insurance help first, or compare two programs directly. This guide is educational and not medical advice; a licensed clinician decides whether a GLP-1 is right for you.

Frequently asked questions

Can I get a GLP-1 without insurance?

Yes. You can go through a telehealth clinic that prescribes compounded semaglutide or tirzepatide, buy a brand-name drug through a manufacturer's direct cash program, or see a local prescriber and pay a cash pharmacy price. All three require a licensed clinician's prescription.

What is the cheapest way to get a GLP-1 without insurance?

For most cash-paying patients, telehealth with compounded medication is the lowest monthly cost. The trade-off is that compounded drugs are not FDA-approved. Compare the all-in maintenance-dose price, not the introductory rate.

Do I need a prescription to get a GLP-1 without insurance?

Yes. A licensed clinician must evaluate you and write the prescription on every legitimate route, including online telehealth. Any site that skips the clinician entirely is a warning sign, not a shortcut.

References

  1. Wilding JPH, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
  2. Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/
  3. U.S. Food and Drug Administration (2024). FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA Drug Alerts and Statements. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  4. Knop FK, et al. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1). The Lancet. https://pubmed.ncbi.nlm.nih.gov/37385278/
  5. Rubino D, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity (STEP 4). JAMA. https://pubmed.ncbi.nlm.nih.gov/33755728/

Reported, not prescribed. Everything on this page is journalism and general education — not a diagnosis, a treatment plan, or a recommendation to start or stop any medication. Your history, hormones, and pregnancy plans are yours alone; only a licensed clinician who knows them can advise you. Talk to one before you act on anything you read here.